Načítá se...
COVID-19 alters thinking and management in metabolic diseases
Metabolic diseases emerged as important risk factors for severe COVID-19, but the mechanisms responsible remained unclear for some time. The severity of metabolic diseases was also associated with worse outcomes in patients with COVID-19, forcing clinicians to adjust their thinking on which patients...
Uloženo v:
| Vydáno v: | Nat Rev Endocrinol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group UK
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7687210/ https://ncbi.nlm.nih.gov/pubmed/33239662 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41574-020-00449-y |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|